Approvals/TGA/SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial

Approved

STANDARD

SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial

Gilead Sciences Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: a99e7677893c2385
Product Name: SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial
Artg Id: 386895
Artg Name: SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial
Sponsor: Gilead Sciences Pty Ltd
Company Detail Path: /organization/gilead-sciences-pty-limited
Artg Date: 2023-03-27
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/8427e27b3e6d432d7d6ad0900966e6c9.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/9ea0c8d55e86c33b59441be9c42ca8da.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

a99e7677893c2385

Type

Standard